logo
episode-header-image
May 19
11m 49s

Electricity Powers New Frontier in Cance...

The Wall Street Journal
About this episode
Long used to power implantable devices like pacemakers, electricity is now gaining traction as a possible treatment for diseases such as cancer. WSJ health reporter Brianna Abbott tells us how clinical trials are showing early promise. Plus: Meta is contending with an ‘epidemic of scams’ on its platforms as criminals flood Instagram and Facebook. WSJ tech re ... Show More
Up next
Aug 22
TNB Tech Minute: Waymo Is Headed to the Big Apple
Plus: TikTok to lay off hundreds of U.K. content moderators in AI push. And ESPN and MLB are closing in on a three-year streaming deal worth around $1.65 billion. Julie Chang hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices 
2m 32s
Aug 22
TNB Tech Minute: Elon Musk Tried to Enlist Mark Zuckerberg to Join OpenAI Bid
Plus: The Trump administration considers taking equity stakes in companies receiving funds from the 2022 Chips Act. And AI spurs funding rebounds for healthtech startups. Zoe Kuhlkin hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices 
2m 17s
Aug 22
Tech Giants Struggle to Live Up to Affordable Housing Promises
Meta Platforms, Google and Apple pledged billions of dollars to make housing more affordable in Silicon Valley. Six years later, the results haven’t lived up to expectations. WSJ reporter Nicole Friedman joins us to explain why. And WSJ personal tech columnist Nicole Nguyen share ... Show More
12m 33s
Recommended Episodes
Jan 2025
A golden age of cancer treatment?
The Guardian’s health editor Andrew Gregory explores the promises and challenges of revolutionary technology in the fight against cancer. Help support our independent journalism at theguardian.com/infocus 
28m 26s
Jan 2025
Fraudsters Stole Billions in Jobless Benefits. They Might Get Away With It
P.M. Edition for Jan. 16. Fraudsters stole billions via government jobless claims during the pandemic. WSJ U.S. economy reporter Paul Kiernan tells us why time is running out to prosecute them. And, TikTok’s CEO plans to attend Donald Trump’s inauguration, news that comes days be ... Show More
13m 49s
Oct 2024
The Mystery $30 Million Crypto Bets on a Trump Win
P.M. Edition for Oct. 18. WSJ reporter Alexander Osipovich discusses a wave of pro-Trump bets in one popular betting market. And Journal health reporter Anna Wilde Mathews discusses why CVS Health is getting a new chief executive and a new strategy. Plus, U.S. federal regulators ... Show More
14m 18s
Jun 10
ICE Protests Spread to San Francisco
A.M. Edition for June 10. Protests against President Trump’s immigration policies spread beyond Los Angeles. Plus, WSJ reporter Ed Ballard breaks down a potential policy shift by the World Bank that would allow it to fund nuclear power projects across the developing world. And th ... Show More
15m 10s
May 5
Trump trade negotiations, new cancer treatment study, Met Gala preview & more
President Donald Trump weighed in on talks with US trade partners. Europe unveiled a push to attract researchers amid America’s changes to science policy. The Department of Homeland Security is offering undocumented migrants an incentive to self-deport. Researchers found a treatm ... Show More
6m 51s
Apr 2025
Investors Cheer a Tariff Rollback for the Tech Industry
A.M. Edition for April 14. Global stocks rise after a Friday filing showed that smartphones, computers and other categories of tech products will be exempt from sweeping tariffs imposed earlier this month. WSJ markets reporter Caitlin McCabe surveys how equities are responding. P ... Show More
13m 13s
Nov 2024
Can AI Startups Keep Powering Big Tech’s Spending Spree?
A.M. Edition for Nov. 1. WSJ global tech editor Jason Dean breaks down the results of this week’s tech earnings amid investor concern over soaring capital expenditures. Plus, Boeing offers machinists a 38% raise over four years as it tries to end a monthslong strike. And the WSJ’ ... Show More
14m 40s
Feb 2025
Chinese Biotech Is Having A DeepSeek Moment
P.M. Edition for Feb. 7. China’s biotech industry is creating new drugs more cheaply and quickly than its U.S. counterparts. WSJ Heard on the Street columnist David Wainer tells us what’s behind the sector’s rise. Plus, new data show the U.S. economy added fewer jobs than expecte ... Show More
13m 48s